Abacus Fcf Advisors LLC / GILD
Abacus Fcf Advisors LLC’s Gilead Sciences Inc Position
Does Abacus Fcf Advisors LLC own Gilead Sciences Inc (GILD)? Yes — 82.6K shares worth $12M (+2.59% of its 13F portfolio) as of Q1 2026, down from 142.0K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
82.6K
% of Portfolio
+2.59%
Quarters Held
20
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 82.6K | $12M | +2.59% |
| Q4 2025 | 142.0K | $17M | +2.28% |
| Q3 2025 | 138.7K | $15M | +2.05% |
| Q2 2025 | 165.0K | $18M | +2.56% |
| Q1 2025 | 162.2K | $18M | +2.85% |
| Q4 2024 | 125.9K | $12M | +1.53% |
| Q3 2024 | 75.5K | $6M | +1.47% |
| Q2 2024 | 69.6K | $5M | +1.19% |
| Q1 2024 | 62.9K | $5M | +1.15% |
| Q4 2023 | 57.8K | $5M | +1.36% |
| Q3 2023 | 23.5K | $2M | +0.93% |
| Q2 2023 | 24.1K | $2M | +0.94% |
| Q1 2023 | 24.3K | $2M | +1.08% |
| Q4 2022 | 13.6K | $1M | +0.76% |
| Q3 2022 | 13.9K | $858,000 | +0.59% |
| Q2 2022 | 14.9K | $924,000 | +0.57% |
| Q1 2022 | 23.9K | $1M | +0.48% |
| Q3 2020 | 27.0K | $2M | +0.93% |
| Q2 2020 | 17.3K | $1M | +1.26% |
| Q1 2020 | 18.1K | $1M | +1.51% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abacus Fcf Advisors LLC’s full portfolio or all institutional holders of GILD.